Abstract

Acharya Manish Ji, Dr. Gitika Chaudhary*, Dr. Richa, Dr. Suyash Pratap Singh and Dr. Ankit Sharma

ABSTRACT

Chronic Kidney Disease (CKD) has emerged as a prevalent condition in contemporary society, affecting individuals across various age groups, including younger populations. The conventional therapeutic options, such as dialysis and renal transplantation, remain financially inaccessible for a significant proportion of the Indian population, limiting their ability to achieve a healthy and satisfactory life. Consequently, there is a growing demand for alternative, sustainable approaches to managing CKD. CKD is characterized by its chronic and progressive nature, resulting in irreversible kidney damage. The primary contributing factors in most cases are uncontrolled hypertension and type 2 diabetes mellitus, which often remain asymptomatic during the early stages. As the disease advances, symptoms such as swelling in the lower limbs, loss of appetite, nausea, reduced urine output or difficulty in urination, frothy or foamy urine, and persistent fatigue become evident. Diagnosis typically involves laboratory investigations, including kidney function tests, which reveal elevated serum urea and creatinine levels—markers of impaired renal filtration. Additionally, reduced erythropoietin production, a critical hormone for red blood cell production, contributes to anemia and a decline in hemoglobin levels. This article presents the case of a 48-year-old male diagnosed with CKD for four years and hypertension for ten years. He reported symptoms of generalized weakness, hyperacidity, gaseous distension, muscle cramps, and flank pain. Integrative Ayurvedic management was implemented, incorporating personalized Panchakarma with Ayurvedic formulations, dietary modifications, and lifestyle adjustments. The patient experienced significant symptomatic relief and improvement in overall wellbeing. The findings underscore the potential of Ayurveda as a cost-effective and holistic approach to improving the quality of life in CKD patients, addressing the challenges posed by financial constraints and the limitations of conventional treatment modalities.